Bristol Myers Squibb 在 AWS 上建置企業資料湖

Exscientia uses generative artificial intelligence (AI) throughout the design-make-test-learn (DMTL) cycle to discover new therapies for patients quickly and relatively inexpensively. Conventional drug discovery methods can take up to 15 years and cost over 2 billion dollars, with an average failure rate of 90–96 percent because scientists hunt for specific drug candidates among 1060 bioavailable small molecules.

Rush University System for Health is reducing the life expectancy gap and addressing the social determinants of health with its Health Equity Care & Analytics Platform built on AWS.

Siemens uses an array of AWS services to bring IIOT to railways and factories, developing intelligent infrastructure for buildings and distributed energy systems, implementing AI into its cybersecurity platform, and more.